Neuronetics, Inc.
STIM
NASDAQ·Healthcare·Medical - Devices·Mkt cap $200.4M
$2.88
▲ +5.88%
P/E
-6.70
Mkt Cap
$200.4M
52-Wk Range
$0.80–$3.71
52-Week Range
$0.80 - $3.71
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 14.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- FDA-cleared, clinically-proven transcranial magnetic stimulation technology with established safety profile
- Non-invasive, non-systemic treatment approach reducing medication dependency and side effects
- Established direct sales infrastructure and relationships with psychiatrists and mental health providers
- Proprietary MRI-strength magnetic field technology differentiated from competitor offerings
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising prevalence of major depressive disorder and treatment-resistant depression globally
Value
Deep value opportunity - significant discount to Life Sciences Tools peers
Momentum
Hot
+125.0% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying STIM right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 11, 2026
Reported EPS of -$0.05 vs -$0.12 consensus (+59.4% surprise). Revenue of $41.6M vs $40.2M expected (+3.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+59.4%
Revenue trend · last 8Q
—
+11%
+84%
+132%
+101%
+86%
+8%
+9%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$18.5M
$22.5M
$32.0M
$38.1M
$37.3M
$41.8M
$34.5M
$41.6M
Margins · last 8Q
Gross
51.1%
Operating
-3.6%
Profit
-8.3%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · Jul 20, 2026
vs Industry
How STIM stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related